Page last updated: 2024-08-25

sofosbuvir and Diabetes Mellitus, Adult-Onset

sofosbuvir has been researched along with Diabetes Mellitus, Adult-Onset in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's4 (66.67)2.80

Authors

AuthorsStudies
Buti, M; Castellanos Fernández, MI; Chan, WK; Duseja, A; El-Kassas, M; Esmat, G; Gordon, SC; Hamid, S; Henry, L; Isakov, V; Lam, B; Méndez-Sánchez, N; Nader, F; Ong, JP; Papatheodoridis, G; Racila, A; Romero-Gómez, M; Stepanova, M; Yilmaz, Y; Younossi, I; Younossi, ZM; Yu, ML; Ziayee, M1
Abdel Moneim, A; Mabrouk, D; Mahmoud, B; Suleiman, HA; Zaky, MY1
Abdel Alem, S; Abdellatif, Z; Abdo, M; Moustafa, A; Rabiee, A1
Abdel Alem, S; Abdellatif, Z; Adel, E; Elsharkawy, A; Esmat, G; Fouad, R; Hussein, MS; Musa, S; Nagy, A; Yosry, A1
Bahra, M; Blaeker, H; Dürr, M; Eurich, D; Eurich, F; Globke, B; Maurer, MM; Pratschke, J; Teegen, EM; Vollbort, A1
Allam, AS; Hussein, HA; Moaty, ASA1

Trials

1 trial(s) available for sofosbuvir and Diabetes Mellitus, Adult-Onset

ArticleYear
Viral clearance ameliorates hematological and inflammatory markers among diabetic patients infected with hepatitis C genotype 4.
    Clinical and experimental medicine, 2020, Volume: 20, Issue:2

    Topics: Adult; Antiviral Agents; Biomarkers; Carbamates; Diabetes Mellitus, Type 2; Female; Genotype; Glycated Hemoglobin; Hepacivirus; Hepatitis C; Humans; Imidazoles; Inflammation; Insulin Resistance; Interleukin-1beta; Male; Middle Aged; Pyrrolidines; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine

2020

Other Studies

5 other study(ies) available for sofosbuvir and Diabetes Mellitus, Adult-Onset

ArticleYear
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry.
    Journal of viral hepatitis, 2022, Volume: 29, Issue:11

    Topics: Antiviral Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fatigue; Female; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Patient Reported Outcome Measures; Quality of Life; Registries; Sofosbuvir

2022
Impact of sustained virological response on metabolic disorders in diabetic chronic hepatitis C virus patients after treatment with generic sofosbuvir and daclatasvir.
    European journal of gastroenterology & hepatology, 2021, 12-01, Volume: 33, Issue:12

    Topics: Antiviral Agents; Carbamates; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Pyrrolidines; Retrospective Studies; Ribavirin; Sofosbuvir; Treatment Outcome; Valine

2021
Improvement of glycemic state among responders to Sofosbuvir-based treatment regimens: Single center experience.
    Journal of medical virology, 2017, Volume: 89, Issue:12

    Topics: Aged; Antiviral Agents; Blood Glucose; Diabetes Mellitus, Type 2; Egypt; Female; Glycated Hemoglobin; Glycemic Index; Hepacivirus; Hepatitis C, Chronic; Humans; Insulin Resistance; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Ribavirin; Sofosbuvir

2017
Evaluation of histological dynamics, kidney function and diabetes in liver transplant patients after antiviral treatment with direct-acting antivirals: Therapy of HCV-recurrence.
    Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:1

    Topics: Aged; Aged, 80 and over; Allografts; Antiviral Agents; Biopsy; Diabetes Mellitus, Type 2; Drug Therapy, Combination; End Stage Liver Disease; Female; Fibrosis; Glomerular Filtration Rate; Hepacivirus; Hepatitis C, Chronic; Humans; Kidney; Liver; Liver Transplantation; Male; Middle Aged; Recurrence; Sofosbuvir; Sustained Virologic Response

2019
Evaluation of Glycated Haemoglobin (HbA1c) Level in Type 2 Diabetic Chronic HCV Non-cirrhotic Treatment-Naïve Egyptian Patients Eradicated with Sofosbuvir Plus Daclatasvir.
    Current diabetes reviews, 2020, Volume: 16, Issue:2

    Topics: Antiviral Agents; Blood Glucose; Carbamates; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Egypt; Female; Glycated Hemoglobin; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Prospective Studies; Pyrrolidines; Risk Factors; Sofosbuvir; Treatment Outcome; Valine

2020